Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.11 (
AMPK
)
12,425
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Maslinic acid
(MA), a natural triterpenoid abundant in olives, has a variety of bioactivities. However, its effects and mechanisms on colorectal cancer (CRC) still need to be explored. This research evaluated the effects of MA on CRC progression from the aspect of the adenosine monophosphate (AMP)-activated protein kinase (
AMPK
)-mammalian target of rapamycin (mTOR) pathway. MA inhibited the proliferation and migration of HCT116 and SW480 cells while inducing apoptosis in these cells. Furthermore, it could activate
AMPK
and negatively regulate the mTOR pathway. Knockdown of
AMPK
abolished its inhibitory effect on cell proliferation and migration and blocked the MA-induced apoptosis, revealing that
AMPK
was associated with the anticancer activity of MA. In addition, MA significantly suppressed the tumorigenesis and regulated the
AMPK
-mTOR pathway in azoxymethane/dextran sulfate sodium mice and xenograft tumor mice. This study demonstrated that the regulation of
AMPK
-mTOR signaling could potentially contribute to the beneficial effects of MA, including the prevention of CRC.
...
PMID:Maslinic Acid Inhibits Colon Tumorigenesis by the AMPK-mTOR Signaling Pathway. 3091 81
Maslinic acid
is a pentacyclic triterpenoid that is distributed in the peel of olives. Previous studies found that
maslinic acid
inhibited inflammatory response and antioxidant effects. We investigated whether
maslinic acid
ameliorates nonalcoholic fatty liver disease in mice with high-fat-diet (HFD)-induced obesity and evaluated the regulation of lipogenesis in hepatocytes. Male C57BL/6 mice fed a normal diet or HFD (60% fat, w/w) were tested for 16 wk. After the fourth week, mice were injected intraperitoneally with
maslinic acid
for 12 wk. In another experiment, HepG2 cells were treated with oleic acid to induce lipid accumulation or
maslinic acid
to evaluate lipogenesis.
Maslinic acid
significantly reduced body weight compared with HFD-fed mice.
Maslinic acid
reduced liver weight and liver lipid accumulation and improved hepatocyte steatosis. Furthermore, serum glucose, leptin, and free fatty acid concentrations significantly reduced, but the serum adiponectin concentration was higher, in the
maslinic acid
group than in the HFD group. In liver tissue,
maslinic acid
suppressed transcription factors involved in lipogenesis and increased adipose triglyceride lipase.
In vitro
,
maslinic acid
decreased lipogenesis by activating
AMPK
. These findings suggest that
maslinic acid
acts against hepatic steatosis by regulating enzyme activity involved in lipogenesis, lipolysis, and fatty acid oxidation in the liver.-Liou, C.-J., Dai, Y.-W., Wang, C.-L., Fang, L.-W., Huang, W.-C.
Maslinic acid
protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/
AMPK
signaling pathway.
...
PMID:Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. 3136 24